Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries.
Siemens said the acquisition was “complementary” to its expansion into Life Sciences and would lift its game in a market needing more medication innovation as populations age.
“These trends underscore the need for digital transformation, with software spending expected to double over the next five years,” Siemens said in a statement.
The German group said that it expected Dotmatics to be immediately profitable, and to bring in $100 million a year in revenue over the mid-term, rising to $500 million in the long-term.
It said the transaction would be completed in the first half of next year.
Siemens recently bought another US software firm also using AI, Altair Engineering, for $10 billion.
Dotmatics, founded in 2005 and with a workforce of 800 people, presents itself as a leader in R&D software, and has a platform using AI to accelerate drug research.
Siemens, Germany’s second-biggest company by market capitalization, has been seeing increased revenues from its software division as its digital products for factories face a slump.
© 2025 AFP
Citation:
Siemens buys US firm Dotmatics for $5.1 bn in AI software push (2025, April 3)
retrieved 3 April 2025
from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
Leave a comment